tiprankstipranks
Trending News
More News >
Changmao Biochemical Engineering Co. Ltd. Class H (DE:CZB)
BERLIN:CZB
Advertisement

Changmao Biochemical Engineering Co. Ltd. Class H (CZB) Price & Analysis

Compare
0 Followers

CZB Stock Chart & Stats


Changmao Biochemical Engineering Co. Ltd. Class H News

CZB FAQ

What was Changmao Biochemical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Changmao Biochemical Engineering Co. Ltd. Class H lowest stock price was €0.03 and its highest was €0.06 in the past 12 months.
    What is Changmao Biochemical Engineering Co. Ltd. Class H’s market cap?
    Changmao Biochemical Engineering Co. Ltd. Class H’s market cap is €18.06M.
      When is Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date?
      Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date is Mar 31, 2026 which is in 207 days.
        How were Changmao Biochemical Engineering Co. Ltd. Class H’s earnings last quarter?
        Changmao Biochemical Engineering Co. Ltd. Class H released its earnings results on Aug 18, 2025. The company reported -€0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.006.
          Is Changmao Biochemical Engineering Co. Ltd. Class H overvalued?
          According to Wall Street analysts Changmao Biochemical Engineering Co. Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Changmao Biochemical Engineering Co. Ltd. Class H pay dividends?
            Changmao Biochemical Engineering Co. Ltd. Class H does not currently pay dividends.
            What is Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate?
            Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Changmao Biochemical Engineering Co. Ltd. Class H have?
            Changmao Biochemical Engineering Co. Ltd. Class H has 183,700,000 shares outstanding.
              What happened to Changmao Biochemical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
              Changmao Biochemical Engineering Co. Ltd. Class H reported an EPS of -€0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Changmao Biochemical Engineering Co. Ltd. Class H?
                Currently, no hedge funds are holding shares in DE:CZB

                Company Description

                Changmao Biochemical Engineering Co. Ltd. Class H

                Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, pharmaceutical adjuvant, and active pharmaceutical ingredient, etc. The company is also involved in the research and development of medicine and nutraceutical products; production and sale of food additives; trading of organic acids; and property holding activities. Changmao Biochemical Engineering Company Limited was founded in 1992 and is headquartered in Changzhou, the People's Republic of China.

                Changmao Biochemical Engineering Co. Ltd. Class H (CZB) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Ko Yo Chemical (Group) Limited
                Tiande Chemical Holdings Limited
                Dongguang Chemical Ltd.
                China Sanjiang Fine Chemicals Co., Ltd.
                Lee & Man Chemical Co. Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis